Sigmoid Colon Cancer Clinical Trial
Official title:
The Effects of Mechnikov Probiotics on Symptom and Surgical Outcome After Anterior Resection of Colon Cancer; Double-blind, Randomized, Placebo-controlled Trial
The purpose of this clinical trial study was to evaluate the prevalence of colon cancer among the symptom (s) of anterior resection syndrome that may occur after surgery in patients for efficacy and safety in Metchnik probiotic ingestion.
The purpose of the clinical trial is to evaluate the efficacy and safety of the syndrome that may occur after colon cancer surgery, To evaluate the efficacy and safety of the improvement effect of the defecatory activity on the improvement of the Medienkov probiotics biotics on the patients who have the deficit function and planned to surgery. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00607282 -
Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer
|
Phase 2 | |
Completed |
NCT03259828 -
Sigmoid Colon Organ Motion in Radiotherapy
|
N/A | |
Recruiting |
NCT05943041 -
Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer
|
Phase 1 |